CliffBio
small molecule

ZUBSOLV

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Loss of exclusivitySeptember 2032latest FDA-listed patent expiry
CompanyEDENBRIDGE PHARMACEUTICALS LLC DBA DEXCEL PHARMA USA

Drug detail

Brand nameZUBSOLV
Active ingredientBUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
StrengthEQ 0.7MG BASE;EQ 0.18MG BASE
Dosage formTABLET
RouteSUBLINGUAL
ModalitySmall molecule
FDA approvalOctober 2016
Marketing statusRX

Listed patents

PatentExpiresType
11020388September 2032product
10946010September 2032product
9259421September 2032product
8940330September 2032product
8470361May 2030product
8658198December 2027product

More from EDENBRIDGE PHARMACEUTICALS LLC DBA DEXCEL PHARMA USA

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Not found